This inventor holds 2 USPTO granted patents. Top assignees: Dso National Laboratories, National University of Singapore. Active years: 1999-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2012
Title: Weng Keong Loke: Innovator in Biochemical Detection and Tissue Preservation
Introduction
Weng Keong Loke is a notable inventor based in Singapore, recognized for his contributions to the fields of biochemical detection and tissue preservation. With a total of 2 patents, he has developed innovative methods that have significant implications in medical and biological applications.
Latest Patents
One of his latest patents is a method of detecting an amount of a cholinesterase inhibitor in a sample. This method involves several steps, including contacting the sample with an agent that recovers the cholinesterase inhibitor, isolating the inhibitor, and measuring its activity to determine its concentration. Another significant patent is a method for reducing calcification of biological tissue used in implantable devices. This process treats biological materials with dimethyl sulfoxide to delay calcification, ensuring that materials such as porcine aortic valves and pericardium remain effective for longer periods without adverse effects.
Career Highlights
Weng Keong Loke has worked with prestigious institutions, including the National University of Singapore and DSO National Laboratories. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Throughout his career, he has collaborated with notable colleagues such as Eugene Khor and Yong Teng Tan. These partnerships have fostered innovation and enhanced the impact of his research.
Conclusion
Weng Keong Loke's innovative patents and career achievements highlight his significant role in advancing biochemical detection and tissue preservation technologies. His work continues to influence the medical field and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
